Patient info Search Menu

Cinacalcet 30 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
30 mg
Contains active substance:
ATC code:
Similar medicines?:

Patient leaflet - Cinacalcet 30 mg film-coated tablets

1. What Cinacalcet is and what it is used for

Cinacalcet contains the active ingredient cinacalcet, which works by controlling the levels of parathyroid hormone (PTH), calcium and phosphorous in your body. It is used to treat problems with organs called parathyroid glands. The parathyroids are four small glands in the neck, near the thyroid gland, that produce parathyroid hormone (PTH).

Cinacalcet is used in adults:

  • to treat secondary hyperparathyroidism

    in adults with serious kidney disease who need dialysis to clear their blood of waste products

  • to reduce high levels of calcium in the blood

    (hypercalcaemia) in adult patients with parathyroid cancer

  • to reduce high levels of calcium in the blood

    (hypercalcaemia) in adult patients with primary hyperparathyroidism when removal of the parathyroid gland is not possible. Cinacalcet is used in children aged 3 years to less than 18 years of age:

  • to treat secondary hyperparathyroidism in

    patients with serious kidney disease who need dialysis to clear their blood of waste products, whose condition is not controlled with other treatments.

In primary and secondary hyperparathyroidism too much PTH is produced by the parathyroid glands. “Primary” means that the

hyperparathyroidism is not caused by any other condition and “secondary” means that the hyperparathyroidism is caused by another condition, e.g. kidney disease. Both primary and secondary hyperparathyroidism can cause the loss of calcium in the bones, which can lead to bone pain and fractures, problems with blood and heart vessels, kidney stones, mental illness and coma.

2. What you need to know before you take Cinacalcet

Do not take Cinacalcet:

  • if you are allergic to cinacalcet or any of the

    other ingredients of this medicine (listed in section 6).

  • if you have low levels of calcium in your

    blood. Your doctor will monitor your blood calcium levels.

Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Cinacalcet.

Before you start taking Cinacalcet, tell your doctor if you have or have ever had:

  • seizures (fits or convulsions). The risk of having

    seizures is higher if you have had them before;

  • liver problems;
  • heart failure.
05/06/26 4137867
24137867
NAART-31454-02

3. How to take Cinacalcet

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are unsure. Your doctor will tell you how much Cinacalcet you must take.

Cinacalcet must be taken orally, with or shortly after food. The tablets must be taken whole and are not to be chewed, crushed or divided. Your doctor will take regular blood samples during treatment to monitor your progress and will adjust your dose if necessary.

If you are being treated for secondary hyperparathyroidism

The recommended starting dose for Cinacalcet in adults is 30 mg (one tablet) once per day. The recommended starting dose of Cinacalcet for children aged 3 years to less than 18 years of age is no more than 0.20 mg/kg of body weight daily.

If you are being treated for parathyroid cancer or primary hyperparathyroidism

The recommended starting dose for Cinacalcet in adults is 30 mg (one tablet) twice per day.

If you take more Cinacalcet than you should

If you take more Cinacalcet than you should you must contact your doctor immediately. Possible signs of overdose include numbness or tingling around the mouth, muscle aches or cramps and seizures.

If you forget to take Cinacalcet

Do not take a double dose to make up for a forgotten dose.

If you have forgotten a dose of Cinacalcet, you should take your next dose as normal. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Please tell your doctor immediately:

  • If you start to get numbness or tingling

    around the mouth, muscle aches or cramps and seizures. These may be signs that your calcium levels are too low (hypocalcaemia).

  • If you experience swelling of the face,

    lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing (angioedema).

Other possible side effects:

Very common: may affect more than 1 in 10 people:

  • nausea and vomiting, these side effects are

    normally quite mild and do not last for long. Common: may affect up to 1 in 10 people:

  • dizziness
  • numbness or tingling sensation (paraesthesia)
  • loss (anorexia) or decrease of appetite
  • muscle pain (myalgia)
  • weakness (asthenia)
  • rash
  • reduced testosterone levels
  • high potassium levels in the blood

    (hyperkalaemia)

  • allergic reactions (hypersensitivity)
  • headache
  • seizures (convulsions or fits)
  • low blood pressure (hypotension)
  • upper respiratory infection
  • breathing difficulties (dyspnoea)
  • cough
  • indigestion (dyspepsia)
  • diarrhoea
  • abdominal pain, abdominal pain - upper
  • constipation
  • muscle spasms
  • back pain
  • low calcium levels in the blood

    (hypocalcaemia).

Not known: frequency cannot be estimated from the available data:

  • Hives (urticaria).
  • Swelling of the face, lips, mouth, tongue

    or throat which may cause difficulty in swallowing or breathing (angioedema).

  • Unusually fast or pounding heart beat

    which may be associated with low levels of calcium in your blood (QT prolongation and ventricular arrhythmia secondary to hypocalcaemia).

    After taking cinacalcet a very small number of patients with heart failure had worsening of their condition and/or low blood pressure (hypotension).

    Reporting of side effects

    If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via

    United Kingdom

    Yellow Card Scheme

    Website: www.mhra.gov.uk/yellowcard Or search for MHRA Yellow Card in the Google Play or Apple App Store.

5. How to store Cinacalcet

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister, carton or bottle after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Cinacalcet contains

The active substance is cinacalcet. Each film-coated tablet contains 30 mg, 60 mg or 90 mg of cinacalcet (as hydrochloride). The other ingredients are cellulose, microcrystalline; silica, colloidal anhydrous; povidone; crospovidone; magnesium stearate. The tablet coating contains hypromellose, titanium dioxide (E171), triacetin, indigo carmine (E132), iron oxide yellow (E172). What Cinacalcet looks like and contents of the pack

Cinacalcet 30 mg film-coated tablets are 10.0 mm x 6.4 mm, green, oval, biconvex, bevelled edge tablets marked with M on one side of the tablet and CI30 on the other side. Cinacalcet 60 mg film-coated tablets are 12.5 mm x 8.0 mm, green, oval, biconvex, bevelled edge tablets marked with M on one side of the tablet and CI60 on the other side. Cinacalcet 90 mg film-coated tablets are 14.3 mm x 9.0 mm, green, oval, biconvex, bevelled edge tablets marked with M on one side of the tablet CI90 on the other side. Cinacalcet 30 mg, 60 mg, 90 mg film-coated tablets are available in blister packs of 28 tablets and perforated unit dose blister packs of 28 x 1, 30 x 1 and 84 x 1 tablets.

Cinacalcet 30 mg film-coated tablets are available in plastic bottles of 100 tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder

Viatris,

Station Close,

Potters Bar,

EN6 1TL,

United Kingdom.

Manufacturers

Mylan Hungary Kft,

H-2900 Komárom,

Mylan utca 1,

Hungary.

Mylan Germany GmbH,

Zweigniederlassung Bad Homburg v. d. Hoehe, Benzstrasse 1,

Bad Homburg v. d. Hoehe,

Hessen,

61352,

Germany.

Viatris UK Healthcare Limited,

Building 20,

Station Close,

Potters Bar,

EN6 1TL,

United Kingdom.

This leaflet was last revised in July 2026

4137867 75113048

05/06/26 4137867
24137867
NAART-31454-02

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 04569/1986

Last revision stated in the text: July 2026 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Cinacalcet 30 mg film-coated tablets

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Cinacalcet
Strength? 30 mg
Pharmaceutical form? Oral tablet
Cinacalcet 30 mg film-coated tablets
10.0 mm x 6.4 mm, green, film-coated, oval, biconvex, bevelled edge tablet debossed with M on one side of the tablet and CI30 on the other side.
How is it taken? Oral
Excipients? Cellulose, microcrystalline, Silica, colloidal anhydrous, Povidone, Crospovidone (type A), Magnesium stearate, Hypromellose, Titanium dioxide (E171), Triacetin, Indigo carmine aluminium lake (E132), Iron oxide yellow (E172)
Pack sizes 28 tablet
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC)? Calcium homeostasis, anti-parathyroid agents
  1. H Systemic hormonal preparations, excl. sex hormones and insulins
    1. H05 Calcium homeostasis
      1. H05B Anti-parathyroid agents
        1. H05BX Other anti-parathyroid agents
          1. H05BX01 cinacalcet
Marketing authorisation? PLGB 04569/1986 (first authorised 1 January 2021)
Marketing authorisation holder? Generics (U.K.) Limited T/A Viatris
Codes? GTIN 5016695925417 · BNF 09050102

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.